Status:
COMPLETED
Patient Preferences for Leadless Pacemakers
Lead Sponsor:
Abbott Medical Devices
Conditions:
Cardiac Rhythm Disorder
Bradycardia
Eligibility:
All Genders
18+ years
Brief Summary
Prospective, non-randomized, multi-center study designed to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers
Detailed Description
The purpose of this study is to quantify patient preferences pertaining to risks and features of conventional transvenous pacemakers and leadless pacemakers. The preference study is designed to elicit...
Eligibility Criteria
Inclusion
- Able to read and speak English to consent to participate in the survey
- Willing and able to use a tablet or computer to complete the survey
- Scheduled to undergo evaluation for a de novo cardiac pacemaker at the study site (patient may or may not have a known indication for a pacemaker at the time)
Exclusion
- None
Key Trial Info
Start Date :
March 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 13 2023
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT05327101
Start Date
March 28 2022
End Date
June 13 2023
Last Update
February 20 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Honor Health
Scottsdale, Arizona, United States, 85258
2
Arrhythmia Research Group
Jonesboro, Arkansas, United States, 72401
3
Arkansas Heart Hospital
Little Rock, Arkansas, United States, 72211
4
Pacific Heart Institute
Santa Monica, California, United States, 90404